NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

T細胞免疫療法的全球市場:產業分析,趨勢,市場規模,2026年為止的預測

T Cell Immunotherapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026

出版商 Infinium Global Research (IGR) 商品編碼 1012422
出版日期 內容資訊 英文 100 Pages
商品交期: 最快1-2個工作天內
價格
T細胞免疫療法的全球市場:產業分析,趨勢,市場規模,2026年為止的預測 T Cell Immunotherapy Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026
出版日期: 2021年04月01日內容資訊: 英文 100 Pages
簡介

全球T細胞免疫療法市場在2020年∼2026年的預測期間內,預計將以15.7%的年複合成長率成長。

本報告提供全球T細胞免疫療法市場的相關調查,提供市場規模和預測,成長及阻礙因素,機會,需求和趨勢,新加入企業的機會的洞察,作用機制·療法類型·產品級·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 報告概要
  • 調查方法
  • 研究途徑

第2章 摘要整理

  • T細胞免疫療法市場概況
  • T細胞免疫療法市場預測
  • T細胞免疫療法市場地區的亮點

第3章 全球T細胞免疫療法市場概要

  • 簡介
  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • COVID-19對T細胞免疫療法市場的影響分析
  • 波特的五力分析
  • IGR-成長矩陣分析
    • 各作用機制
    • 各療法類型
    • 各產品級
    • 各地區
  • T細胞免疫療法市場價值鏈分析

第4章 T細胞免疫療法市場宏觀指標分析

第5章 各作用機制:全球T細胞免疫療法市場

  • 主動免疫治療
  • 被動免疫療法

第6章 各療法類型:全球T細胞免疫療法市場

  • CAR-T
  • TCR
  • TIL

第7章 各產品級:全球T細胞免疫療法市場

  • 單株抗體
  • 腫瘤溶解性病毒療法
  • 雙特異性抗體
  • 細胞激素

第8章 各地區:全球T細胞免疫療法市場(2020-2026)

  • 北美
    • 各作用機制:T細胞免疫療法市場
    • 各療法類型:T細胞免疫療法市場
    • 各產品級:T細胞免疫療法市場
    • 各國:T細胞免疫療法市場
  • 歐洲
    • 各作用機制:T細胞免疫療法市場
    • 各療法類型:T細胞免疫療法市場
    • 各產品級:T細胞免疫療法市場
    • 各國:T細胞免疫療法市場
  • 亞太地區
    • 各作用機制:T細胞免疫療法市場
    • 各療法類型:T細胞免疫療法市場
    • 各產品級:T細胞免疫療法市場
    • 各國:T細胞免疫療法市場
  • 其他地區
    • 各作用機制:T細胞免疫療法市場
    • 各療法類型:T細胞免疫療法市場
    • 各產品級:T細胞免疫療法市場
    • 小各地區:T細胞免疫療法市場

第9章 企業簡介和競爭情形

  • 全球T細胞免疫療法市場上競爭情形
  • 企業概要
    • Adaptimmune Therapeutics
    • Bluebird Bio
    • Innovative Cellular Therapeutics
    • Novartis
    • Sinobioway Cell Therapy
    • Cellectis
    • CARsgen Therapeutics
    • Autolus ltd
    • Celgene
    • 其他
目錄
Product Code: HC0099

The report on the global T cell immunotherapy market provides qualitative and quantitative analysis for the period from 2018 to 2026. The report predicts the global T cell immunotherapy market to grow with a CAGR of 15.70% over the forecast period from 2020-2026. The study on T cell immunotherapy market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

The report on T cell immunotherapy market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global T cell immunotherapy market over the period of 2018 to 2026. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global T cell immunotherapy market over the period of 2018 to 2026. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The growing occurrence of cancer in both children as well as in adults

2) Restraints

  • Extend waiting period for administration of t-cell immunotherapy is expected to hamper the market growth

3) Opportunities

  • The rapidly increasing research and development activities and technological advancement in cancer treatment

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global T cell immunotherapy market is segmented on the basis of mechanism of action, type of therapy, and product class.

The Global T cell immunotherapy market by Mechanism of Action

  • Active Immunotherapy
  • Passive Immunotherapy

The Global T cell immunotherapy market by Type of Therapy

  • CAR-T
  • TCR
  • TIL

The Global T cell immunotherapy market by Product Class

  • Monoclonal Antibodies
  • Oncolytic Virus Therapy
  • Bispecific Antibodies
  • Cytokines

Company Profiles

The companies covered in the report include

  • Adaptimmune Therapeutics
  • Bluebird Bio
  • Innovative Cellular Therapeutics
  • Novartis
  • Sinobioway Cell Therapy
  • Cellectis
  • CARsgen Therapeutics
  • Autolus
  • Celgene
  • Others

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the T cell immunotherapy market .

2. Complete coverage of all the segments in the T cell immunotherapy market to analyze the trends, developments in the global market and forecast of market size up to 2026.

3. Comprehensive analysis of the companies operating in the global T cell immunotherapy market . The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.

4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. T Cell Immunotherapy Market Highlights
  • 2.2. T Cell Immunotherapy Market Projection
  • 2.3. T Cell Immunotherapy Market Regional Highlights

3. Global T Cell Immunotherapy Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the T Cell Immunotherapy Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Mechanism Of Action
    • 3.5.2. IGR-Growth Matrix Analysis by Type Of Therapy
    • 3.5.3. IGR-Growth Matrix Analysis by Product Class
    • 3.5.4. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of T Cell Immunotherapy Market

4. T Cell Immunotherapy Market Macro Indicator Analysis

5. Global T Cell Immunotherapy Market by Mechanism of Action

  • 5.1. Active Immunotherapy
  • 5.2. Passive Immunotherapy

6. Global T Cell Immunotherapy Market by Type of Therapy

  • 6.1. CAR-T
  • 6.2. TCR
  • 6.3. TIL

7. Global T Cell Immunotherapy Market by Product Class

  • 7.1. Monoclonal Antibodies
  • 7.2. Oncolytic Virus Therapy
  • 7.3. Bispecific Antibodies
  • 7.4. Cytokines

8. Global T Cell Immunotherapy Market by Region 2020-2026

  • 8.1. North America
    • 8.1.1. North America T Cell Immunotherapy Market by Mechanism Of Action
    • 8.1.2. North America T Cell Immunotherapy Market by Type Of Therapy
    • 8.1.3. North America T Cell Immunotherapy Market by Product Class
    • 8.1.4. North America T Cell Immunotherapy Market by Country
  • 8.2. Europe
    • 8.2.1. Europe T Cell Immunotherapy Market by Mechanism Of Action
    • 8.2.2. Europe T Cell Immunotherapy Market by Type Of Therapy
    • 8.2.3. Europe T Cell Immunotherapy Market by Product Class
    • 8.2.4. Europe T Cell Immunotherapy Market by Country
  • 8.3. Asia-Pacific
    • 8.3.1. Asia-Pacific T Cell Immunotherapy Market by Mechanism Of Action
    • 8.3.2. Asia-Pacific T Cell Immunotherapy Market by Type Of Therapy
    • 8.3.3. Asia-Pacific T Cell Immunotherapy Market by Product Class
    • 8.3.4. Asia-Pacific T Cell Immunotherapy Market by Country
  • 8.4. RoW
    • 8.4.1. RoW T Cell Immunotherapy Market by Mechanism Of Action
    • 8.4.2. RoW T Cell Immunotherapy Market by Type Of Therapy
    • 8.4.3. RoW T Cell Immunotherapy Market by Product Class
    • 8.4.4. RoW T Cell Immunotherapy Market by Sub-region

9. Company Profiles and Competitive Landscape

  • 9.1. Competitive Landscape in the Global T Cell Immunotherapy Market
  • 9.2. Companies Profiles
    • 9.2.1. Adaptimmune Therapeutics
    • 9.2.2. Bluebird Bio
    • 9.2.3. Innovative Cellular Therapeutics
    • 9.2.4. Novartis
    • 9.2.5. Sinobioway Cell Therapy
    • 9.2.6. Cellectis
    • 9.2.7. CARsgen Therapeutics
    • 9.2.8. Autolus ltd
    • 9.2.9. Celgene
    • 9.2.10. Others